Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 18 | 2024 | 1674 | 1.150 |
Why?
|
| Lysophosphatidylcholines | 3 | 2022 | 77 | 0.770 |
Why?
|
| Pseudouridine | 1 | 2020 | 19 | 0.680 |
Why?
|
| Sphingomyelins | 1 | 2020 | 103 | 0.680 |
Why?
|
| Metabolome | 6 | 2024 | 1008 | 0.660 |
Why?
|
| Ceramides | 1 | 2020 | 202 | 0.630 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2021 | 266 | 0.620 |
Why?
|
| Phosphatidylcholines | 1 | 2020 | 403 | 0.620 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 534 | 0.580 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2023 | 742 | 0.530 |
Why?
|
| Triglycerides | 3 | 2022 | 2441 | 0.530 |
Why?
|
| Hearing Loss | 1 | 2023 | 785 | 0.500 |
Why?
|
| Ovarian Neoplasms | 3 | 2021 | 4904 | 0.480 |
Why?
|
| Case-Control Studies | 18 | 2024 | 22230 | 0.430 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 1379 | 0.430 |
Why?
|
| Nurses | 4 | 2022 | 2503 | 0.380 |
Why?
|
| Lipids | 8 | 2023 | 3317 | 0.350 |
Why?
|
| Chromatography, Liquid | 4 | 2023 | 995 | 0.340 |
Why?
|
| Pulmonary Embolism | 2 | 2024 | 2596 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 12235 | 0.300 |
Why?
|
| Carotenoids | 2 | 2021 | 620 | 0.300 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 21072 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3249 | 0.300 |
Why?
|
| Biological Specimen Banks | 2 | 2023 | 787 | 0.280 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2023 | 1195 | 0.260 |
Why?
|
| Postmenopause | 5 | 2022 | 2517 | 0.260 |
Why?
|
| Longevity | 2 | 2024 | 1085 | 0.250 |
Why?
|
| Epidemiologic Methods | 2 | 2021 | 1325 | 0.240 |
Why?
|
| Pets | 1 | 2024 | 46 | 0.230 |
Why?
|
| Amino Acids | 3 | 2024 | 1711 | 0.220 |
Why?
|
| Carnitine | 3 | 2018 | 253 | 0.200 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2024 | 117 | 0.200 |
Why?
|
| Cortisone | 1 | 2022 | 90 | 0.200 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2024 | 180 | 0.190 |
Why?
|
| Tinnitus | 1 | 2024 | 197 | 0.190 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 160 | 0.190 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1895 | 0.190 |
Why?
|
| Epidemiologic Studies | 2 | 2022 | 677 | 0.190 |
Why?
|
| Isoleucine | 1 | 2021 | 111 | 0.190 |
Why?
|
| Exfoliation Syndrome | 1 | 2022 | 113 | 0.190 |
Why?
|
| Seafood | 1 | 2024 | 395 | 0.190 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 419 | 0.180 |
Why?
|
| Female | 40 | 2024 | 396174 | 0.180 |
Why?
|
| Fish Oils | 1 | 2024 | 483 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2023 | 402 | 0.180 |
Why?
|
| Premenopause | 2 | 2022 | 1039 | 0.170 |
Why?
|
| Carcinogens, Environmental | 1 | 2020 | 70 | 0.170 |
Why?
|
| Prospective Studies | 12 | 2024 | 54804 | 0.170 |
Why?
|
| Sunburn | 1 | 2021 | 156 | 0.170 |
Why?
|
| Leucine | 1 | 2021 | 547 | 0.170 |
Why?
|
| Middle Aged | 25 | 2024 | 223035 | 0.170 |
Why?
|
| Academies and Institutes | 1 | 2022 | 326 | 0.160 |
Why?
|
| Radon | 1 | 2020 | 90 | 0.160 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2024 | 1038 | 0.160 |
Why?
|
| Follow-Up Studies | 8 | 2023 | 39233 | 0.150 |
Why?
|
| Uric Acid | 1 | 2024 | 809 | 0.150 |
Why?
|
| Humans | 49 | 2024 | 766019 | 0.150 |
Why?
|
| Hypoxanthine | 1 | 2018 | 28 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 2108 | 0.150 |
Why?
|
| Tricarboxylic Acids | 1 | 2018 | 26 | 0.150 |
Why?
|
| Proteomics | 3 | 2022 | 3907 | 0.150 |
Why?
|
| Protozoan Proteins | 1 | 2014 | 843 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2022 | 704 | 0.140 |
Why?
|
| Gout | 1 | 2024 | 622 | 0.140 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2020 | 275 | 0.140 |
Why?
|
| Inosine | 1 | 2018 | 129 | 0.140 |
Why?
|
| Intraocular Pressure | 1 | 2023 | 1304 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2023 | 3787 | 0.140 |
Why?
|
| Nuts | 1 | 2019 | 265 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2022 | 557 | 0.140 |
Why?
|
| Hemocytes | 1 | 2016 | 48 | 0.130 |
Why?
|
| Coronary Disease | 2 | 2022 | 5914 | 0.130 |
Why?
|
| Risk Factors | 15 | 2024 | 74837 | 0.130 |
Why?
|
| Plasmodium falciparum | 2 | 2016 | 1737 | 0.130 |
Why?
|
| Diet | 4 | 2024 | 8085 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2023 | 1002 | 0.130 |
Why?
|
| Coffee | 1 | 2020 | 593 | 0.130 |
Why?
|
| Caffeine | 1 | 2020 | 702 | 0.130 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 480 | 0.130 |
Why?
|
| Porphyrins | 1 | 2018 | 351 | 0.130 |
Why?
|
| Adult | 21 | 2024 | 223110 | 0.120 |
Why?
|
| Insect Proteins | 1 | 2016 | 253 | 0.120 |
Why?
|
| Computational Biology | 2 | 2014 | 3563 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 1811 | 0.120 |
Why?
|
| Purines | 1 | 2018 | 616 | 0.110 |
Why?
|
| Anopheles | 1 | 2016 | 193 | 0.110 |
Why?
|
| Endometriosis | 1 | 2022 | 869 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 1804 | 0.110 |
Why?
|
| Child Abuse | 1 | 2022 | 1090 | 0.110 |
Why?
|
| Aged | 13 | 2024 | 171170 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 26280 | 0.100 |
Why?
|
| Risk Assessment | 5 | 2024 | 24272 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2023 | 2646 | 0.100 |
Why?
|
| Adiposity | 2 | 2022 | 1892 | 0.100 |
Why?
|
| Menopause | 1 | 2020 | 1658 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6961 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9525 | 0.100 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2392 | 0.100 |
Why?
|
| Hemoglobins | 1 | 2018 | 1531 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2014 | 12772 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2024 | 3426 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2013 | 2062 | 0.090 |
Why?
|
| Adenoma | 1 | 2022 | 2155 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65203 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4399 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2022 | 2039 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1806 | 0.080 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1102 | 0.080 |
Why?
|
| C-Peptide | 2 | 2023 | 443 | 0.080 |
Why?
|
| Anxiety | 1 | 2024 | 4671 | 0.080 |
Why?
|
| Risk | 1 | 2020 | 9598 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 5882 | 0.070 |
Why?
|
| Gene Expression | 1 | 2020 | 7581 | 0.070 |
Why?
|
| Sleep | 2 | 2023 | 4816 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 12803 | 0.070 |
Why?
|
| Vitamin D | 1 | 2020 | 3270 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1883 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4544 | 0.060 |
Why?
|
| Genomics | 2 | 2023 | 5924 | 0.060 |
Why?
|
| Depression | 1 | 2024 | 8229 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3077 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 18075 | 0.060 |
Why?
|
| Asthma | 1 | 2023 | 6268 | 0.060 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2024 | 50 | 0.050 |
Why?
|
| Life Cycle Stages | 1 | 2014 | 161 | 0.050 |
Why?
|
| Obesity | 3 | 2023 | 13082 | 0.050 |
Why?
|
| Nucleosides | 1 | 2023 | 130 | 0.050 |
Why?
|
| Exercise | 1 | 2019 | 5939 | 0.050 |
Why?
|
| Plasmalogens | 1 | 2022 | 30 | 0.050 |
Why?
|
| Body Mass Index | 4 | 2022 | 13042 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2022 | 130 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 59497 | 0.050 |
Why?
|
| Poultry | 1 | 2022 | 79 | 0.050 |
Why?
|
| Logistic Models | 3 | 2022 | 13272 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 511 | 0.050 |
Why?
|
| Software Design | 1 | 2022 | 173 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 41677 | 0.050 |
Why?
|
| Object Attachment | 1 | 2024 | 327 | 0.050 |
Why?
|
| Glasgow Coma Scale | 1 | 2013 | 574 | 0.050 |
Why?
|
| Adolescent | 5 | 2022 | 88808 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 2543 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2023 | 704 | 0.040 |
Why?
|
| Pelvic Pain | 1 | 2022 | 300 | 0.040 |
Why?
|
| Hearing | 1 | 2023 | 505 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 644 | 0.040 |
Why?
|
| Hormones | 1 | 2022 | 865 | 0.040 |
Why?
|
| Diglycerides | 1 | 2018 | 175 | 0.040 |
Why?
|
| Glutamine | 1 | 2021 | 575 | 0.040 |
Why?
|
| Young Adult | 3 | 2022 | 59858 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2024 | 1156 | 0.040 |
Why?
|
| Pelvis | 1 | 2022 | 737 | 0.040 |
Why?
|
| United States | 5 | 2024 | 72918 | 0.040 |
Why?
|
| Male | 8 | 2024 | 363880 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2019 | 472 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2023 | 808 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 352 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 1505 | 0.030 |
Why?
|
| Benchmarking | 1 | 2023 | 1055 | 0.030 |
Why?
|
| Epidemiology | 1 | 2019 | 278 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14747 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2019 | 751 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 1938 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2013 | 5019 | 0.030 |
Why?
|
| Sex Factors | 2 | 2020 | 10611 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2021 | 1181 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2352 | 0.030 |
Why?
|
| Iran | 1 | 2018 | 760 | 0.030 |
Why?
|
| Algorithms | 3 | 2022 | 14065 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2023 | 1426 | 0.030 |
Why?
|
| Women's Health | 1 | 2024 | 2080 | 0.030 |
Why?
|
| Data Mining | 1 | 2019 | 560 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6057 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1881 | 0.030 |
Why?
|
| Oxygen | 1 | 2024 | 4247 | 0.030 |
Why?
|
| Adiponectin | 1 | 2018 | 1120 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5879 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2646 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 2242 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20135 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1768 | 0.020 |
Why?
|
| Breast | 1 | 2020 | 1950 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2016 | 1517 | 0.020 |
Why?
|
| Leptin | 1 | 2018 | 1596 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2024 | 12426 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 2877 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 22336 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 12529 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11035 | 0.020 |
Why?
|
| Internet | 1 | 2022 | 3107 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 15545 | 0.020 |
Why?
|
| Linear Models | 1 | 2019 | 5872 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2197 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1404 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2024 | 4527 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2020 | 3208 | 0.020 |
Why?
|
| Animals | 4 | 2024 | 168801 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 3106 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 10380 | 0.020 |
Why?
|
| Incidence | 1 | 2024 | 21509 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12061 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 4044 | 0.020 |
Why?
|
| Hospitalization | 1 | 2024 | 10804 | 0.010 |
Why?
|
| Child | 2 | 2023 | 80567 | 0.010 |
Why?
|
| Insulin | 1 | 2018 | 6603 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2018 | 6420 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3664 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14644 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29905 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18382 | 0.010 |
Why?
|
| Liver | 1 | 2017 | 7558 | 0.010 |
Why?
|
| Smoking | 1 | 2018 | 9077 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9378 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 30228 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16714 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 42509 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11906 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81544 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81838 | 0.010 |
Why?
|
Concepts
(218)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_